fromBusiness Insider
2 months agoEli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.
Lilly's pill "outperformed" Novo's "on every key endpoint we measured, including A1C and weight loss," lead trial investigator Dr. Julio Rosenstock, an endocrinologist and diabetes and metabolism expert, said in a release.
Healthcare